Tablon, Elena D.

HRN: 28-68-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/06/2026
04/13/2026
IV
750mg
Now, Then Q 48 Hours
HAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: